|
|
Université
catholique de Louvain
Unité de pharmacologie cellulaire
et moléculaire Unité de microbiologie Cliniques Universitaires
UCL de Mont-Godinne Laboratoire de microbiologie |
|
||
|
|
||||
|
An Interactive
Symposium held on March 29th, 2006 |
||||
|
|
|
|||
|
Session 1: Resistance |
||||
|
|
Mechanisms
of resistance: beta-lactamases et other enzymes ... P.
Nordmann (Hôpital de Bicêtre & Université de Paris XI, Paris, France) |
|||
|
|
Mechanisms
of resistance: porines and efflux ... P. Plésiat
(CHU Jean Minjoz, & Université de Franche-Comté, Besançon, France) |
|||
|
|
Epidemiology
of resistance in the clinics: the situation in France and in Europe
in 2005 M. Roussel-Delvallez (CHRU Hôpital Calmette & Université de Lille 2, Lille, France) |
|||
|
|
Epidemiology of resistance
in the clinics: the situation in Belgium in 2005 J. Van Eldere (UZ-Gasthuisberg & Katholieke Universiteit Leuven, Louvain, Belgium) |
|||
|
|
Methodological and
interpretation problems of the Pseudomonas
antibiogram Y. Glupczynski (Cliniques universitaires de Mont-Godinne & Université catholique de Louvain, Brussels, Belgium) |
|||
|
|
||||
|
Session 2: Therapeutics |
||||
|
|
Present
therapeutic options in Intensive Care Y.
Van Laethem (CHU St-Pierre & Université libre de Bruxelles, Brussels,
Belgium) |
|||
|
|
Present
therapeutic options for multiresistant bacteria |
|||
|
|
Prevention
of Pseudomonas infection in
cystic fibrosis patients P.
Lebecque (Cliniques universitaires Saint-Luc & Université
catholique de Louvain, Bruxelles, Belgium) |
|||
|
|
Present
therapeutic options in cystic fibrosis patients A.
Malfroot (AZ-VUB & Vrije Universiteit Brussel, Brussels, Belgium) |
|||
|
|
New
molecules in the pipeline ? |
|||
|
|
||||
